NCT04351139View on ClinicalTrials.gov

Impact of the COVID-19 Pandemic in Gynecological Oncology

CompletedOBSERVATIONAL
Enrollment

205

Participants

Timeline

Start Date

May 6, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Gynecologic CancerBreast Neoplasm FemaleUterine NeoplasmsOvarian NeoplasmsUterine Cervical NeoplasmsVulvar NeoplasmsVaginal Neoplasms
Interventions
OTHER

modification of the planned therapeutic management

to evaluate the changes in therapeutic management, during the COVID-19 pandemic, of patients suffering from gynecological cancers

Trial Locations (3)

69004

Service de Gynécologie, Croix-Rousse, Hospices Civils de Lyon, Lyon

69310

Service Gynécologie, CHLS, Hospices Civils de Lyon, Pierre-Bénite

69500

Service de Gynécologie, HFME, Hospices Civils de Lyon, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04351139 - Impact of the COVID-19 Pandemic in Gynecological Oncology | Biotech Hunter | Biotech Hunter